Page last updated: 2024-10-22

arotinolol and Diabetes Mellitus, Type 2

arotinolol has been researched along with Diabetes Mellitus, Type 2 in 1 studies

arotinolol: structure given in first source; arotinolol is the (+-)-isomer

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasaki, H1
Naka, K1
Kishi, Y1
Ohoshi, T1
Hagihara, T1
Matsuo, H1
Sowa, R1
Matsumoto, G1
Sanke, T1
Nanjo, K1

Other Studies

1 other study available for arotinolol and Diabetes Mellitus, Type 2

ArticleYear
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
    Diabetes research and clinical practice, 1994, Volume: 26, Issue:1

    Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose;

1994